SCHEMBL3790928

SCHEMBL3790928

Cc1c(C=NO)c(=O)n(C)c(=O)n1C

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 7/20 0.62
ALDH1A1 P00352 8/20 0.41
KDM4E B2RXH2 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 4/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 3/20 0.40
HPGD P15428 3/20 0.39
HSD17B10 Q99714 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TSHR P16473 2/20 0.38
GAA P10253 1/20 0.38
GFER P55789 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790927 1.00 AOC3 (0.62) AOC3ALDH1A1KDM4EL3MBTL1KMT2A
SCHEMBL474635 0.79 AOC3 (0.60) AOC3ALDH1A1KDM4EL3MBTL1KMT2A
SCHEMBL474636 0.79 AOC3 (0.60) AOC3ALDH1A1KDM4EL3MBTL1KMT2A
SCHEMBL16735533 0.77 AOC3 (1.00) AOC3ALDH1A1KDM4EL3MBTL1KMT2A
SCHEMBL16735541 0.77 AOC3 (1.00) AOC3ALDH1A1KDM4EL3MBTL1KMT2A
SCHEMBL2189412 0.77 AOC3 (1.00) AOC3ALDH1A1KDM4EL3MBTL1KMT2A
SCHEMBL2189408 0.77 AOC3 (1.00) AOC3ALDH1A1KDM4EL3MBTL1KMT2A
SCHEMBL2212219 0.77 AOC3 (1.00) AOC3ALDH1A1KDM4EL3MBTL1KMT2A
SCHEMBL2212215 0.77 AOC3 (1.00) AOC3ALDH1A1KDM4EL3MBTL1KMT2A
SCHEMBL3791186 0.75 ALDH1A1 (0.40) AOC3ALDH1A1KDM4EL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010125469-A1 PYRIMIDINEDIONE-FUSED HETEROCYCLIC COMPOUNDS AS TRPA1 MODULATORS GLENMARK PHARMACEUTICALS, S.A. (CH) 2010-11-04 WO disclosed